YD Bio
Bothell
About YD Bio
YD Bio is a biotechnology business that is developing advancements in ophthalmology and DNA methylation-based cancer detection technology.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Total funding: $13.2M
- Funding stage: IPO
- Last round: Post-IPO Equity (Aug 2025)
- Ticker: nasdaq:YDES
- Website: ir.ydesgroup.com
- Phone: +1 (206) 888-0858
Industries & Categories
Biotechnology, Health Care
Social Profiles
Canonical: https://fsome.com/organization/yd-bio-37079 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.